Conor Kilroy
Vermögen: 2 Mio $ am 31.05.2026
Vermögen: 2 Mio $ am 31.05.2026
Conor Kilroy currently works at Aura Biosciences, Inc., as Secretary & Chief Legal Officer from 2025.
Mr. Kilroy also formerly worked at Boston Scientific Corp., as Counsel from 2012 to 2013, Goodwin Procter LLP, as Associate from 2007 to 2011, Ironwood Pharmaceuticals, Inc., as Secretary, Senior Vice President & General Counsel from 2020 to 2021, and Neurogastrx, Inc., as Secretary & General Counsel from 2021 to 2023.
Mr. Kilroy received his undergraduate degree from Brandeis University and graduate degree from Boston College Law School.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AURA BIOSCIENCES INC 0,35 % | 16.04.2026 | 217.835 ( 0,35 % ) | 2 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| AURA BIOSCIENCES, INC. | General Counsel | 01.04.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | General Counsel | 01.05.2023 |
| IRONWOOD PHARMACEUTICALS, INC. | General Counsel | 01.02.2021 |
| BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | 01.01.2013 |
Goodwin Procter LLP
Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Corporate Officer/Principal | 01.01.2011 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
Boston Scientific Corp.
Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Aura Biosciences, Inc.
Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Goodwin Procter LLP
Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Finance |
Brandeis University
Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston College Law School
Boston College Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen